Antibodies to HTLV-III/LAV in Venezuelan Patients with Acute Malarial Infections
- 6 March 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 314 (10) , 647-648
- https://doi.org/10.1056/nejm198603063141013
Abstract
To the Editor: The human T-cell lymphotropic virus, variously called HTLV-III, lymphadenopathy-associated virus (LAV), or acquired immunodeficiency syndrome (AIDS)–related virus, is believed to be the causative agent of AIDS.1 Recently, antibodies reactive with HTLV-III/LAV have been detected among healthy subjects not belonging to any recognized AIDS risk group who live in certain rural regions of Africa2 , 3 and South America.4 Although they are geographically distant, these regions share a tropical climate and an abundance of parasitic infections, including malaria. Malarial infections have been associated with an immunosuppressive state of the host similar to that occurring in AIDS, with manifestations that include . . .Keywords
This publication has 5 references indexed in Scilit:
- ANTIBODIES TO HTLV-III/LAV AMONG ABORIGINAL AMAZONIAN INDIANS IN VENEZUELAThe Lancet, 1985
- Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East AfricaInternational Journal of Cancer, 1985
- Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.BMJ, 1985
- A Pathogenic Retrovirus (HTLV-III) Linked to AIDSNew England Journal of Medicine, 1984
- IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIAThe Lancet, 1978